
Dapaglip5 mg
Incepta Pharmaceuticals Ltd.
Dapagliflozin Propanediol is a sodium-glucose cotransporter-2 (SGLT2) inhibitor approved for the following uses: Established / FDA-approved indications Type 2 diabetes mellitus: Dapagliflozin…
Dapagliflozin Propanediol is a sodium-glucose cotransporter-2 (SGLT2) inhibitor approved for the following uses:
Dapagliflozin Propanediol is always used as part of a comprehensive treatment plan that includes diet, exercise, and, where relevant, other glucose-, blood-pressure-, or lipid-lowering therapies as advised by the treating physician.
| Indication | Recommended dose |
|---|---|
| Type 2 diabetes mellitus (glycemic control) | 5 mg once daily; may be increased to 10 mg once daily if additional glycemic control is needed and tolerated. |
| Heart failure | 10 mg once daily. |
| Chronic kidney disease | 10 mg once daily. |
| Children 10 years and older (type 2 diabetes) | 5 mg once daily; may be increased to 10 mg once daily if needed and tolerated. |
| eGFR | Adjustment |
|---|---|
| ≥45 mL/min/1.73m² | No dose adjustment needed. |
| 25–45 mL/min/1.73m² | May continue at 10 mg once daily for heart failure/CKD indications; not recommended for initiation of the glycemic-control indication at this eGFR. |
| <25 mL/min/1.73m², dialysis, or end-stage renal disease | Initiation not recommended; use only under close physician supervision if already established on therapy for heart failure/CKD, per current renal function. |
No dose adjustment is needed in mild-to-moderate hepatic impairment. Dapagliflozin Propanediol has not been well studied in severe hepatic impairment; use with caution.
Dapagliflozin Propanediol tablets should be swallowed whole with a glass of water, once daily in the morning, with or without food. If a dose is missed, it should be taken as soon as remembered on the same day; two doses should never be taken on the same day to make up for a missed dose. Always take Dapagliflozin Propanediol exactly as prescribed by the physician.
Common and serious side effects reported with Dapagliflozin Propanediol include:
Dapagliflozin Propanediol is contraindicated in the following situations:
Dapagliflozin Propanediol is not indicated for treatment of type 1 diabetes mellitus or diabetic ketoacidosis (see Precautions and Warnings for the associated ketoacidosis risk).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.